Izumi Co Ltd
TSE:8273
Izumi Co Ltd
TSE:8273
Price:
3 177
JPY
0.92%
Market Cap:
227.7B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Izumi Co Ltd
3177
+29 (+0.92%)
| 52 Week Range |
3 059
3 792
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Izumi Co Ltd
Balance Sheet
Balance Sheet Decomposition
Izumi Co Ltd
Izumi Co Ltd
| Current Assets | 124.9B |
| Cash & Short-Term Investments | 16.3B |
| Receivables | 60.7B |
| Other Current Assets | 47.9B |
| Non-Current Assets | 462.6B |
| PP&E | 353.5B |
| Intangibles | 67.1B |
| Other Non-Current Assets | 42B |
| Current Liabilities | 211.6B |
| Accounts Payable | 52.2B |
| Accrued Liabilities | 3B |
| Short-Term Debt | 82B |
| Other Current Liabilities | 74.4B |
| Non-Current Liabilities | 90.4B |
| Long-Term Debt | 29.9B |
| Other Non-Current Liabilities | 60.5B |
Balance Sheet
Izumi Co Ltd
Izumi Co Ltd
Currency: JPY
| Feb-2015 | Feb-2016 | Feb-2017 | Feb-2018 | Feb-2019 | Feb-2020 | Feb-2021 | Feb-2022 | Feb-2023 | Feb-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
13 380
|
13 844
|
10 738
|
8 410
|
8 136
|
8 982
|
25 306
|
11 621
|
10 331
|
11 997
|
|
| Cash Equivalents |
13 380
|
13 844
|
10 738
|
8 410
|
8 136
|
8 982
|
25 306
|
11 621
|
10 331
|
11 997
|
|
| Total Receivables |
27 913
|
30 797
|
32 629
|
36 418
|
39 200
|
45 748
|
41 947
|
42 283
|
46 980
|
51 471
|
|
| Accounts Receivables |
27 913
|
30 797
|
32 629
|
36 418
|
39 200
|
45 748
|
41 947
|
42 283
|
46 980
|
51 471
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
24 985
|
27 148
|
28 178
|
28 580
|
28 935
|
26 328
|
22 139
|
21 157
|
24 387
|
26 260
|
|
| Other Current Assets |
16 414
|
16 919
|
16 519
|
17 654
|
15 893
|
17 244
|
17 720
|
13 806
|
18 369
|
14 425
|
|
| Total Current Assets |
82 692
|
88 708
|
88 064
|
91 062
|
92 164
|
98 302
|
107 112
|
88 867
|
100 067
|
104 153
|
|
| PP&E Net |
304 162
|
325 308
|
335 274
|
333 548
|
338 121
|
337 447
|
330 539
|
329 367
|
328 209
|
334 444
|
|
| PP&E Gross |
304 162
|
325 308
|
335 274
|
333 548
|
338 121
|
337 447
|
330 539
|
329 367
|
328 209
|
334 444
|
|
| Accumulated Depreciation |
211 952
|
242 035
|
254 250
|
261 229
|
271 366
|
279 498
|
287 596
|
302 794
|
309 512
|
320 128
|
|
| Intangible Assets |
7 431
|
8 839
|
8 474
|
8 282
|
8 219
|
8 307
|
8 249
|
9 326
|
10 456
|
10 096
|
|
| Goodwill |
554
|
7 236
|
6 235
|
5 263
|
3 958
|
3 172
|
2 441
|
1 908
|
1 375
|
843
|
|
| Note Receivable |
1 480
|
1 483
|
1 651
|
1 625
|
1 584
|
1 563
|
1 542
|
1 418
|
1 398
|
79
|
|
| Long-Term Investments |
9 460
|
7 746
|
9 703
|
13 266
|
10 396
|
11 039
|
9 876
|
8 729
|
7 931
|
10 540
|
|
| Other Long-Term Assets |
26 637
|
28 706
|
27 484
|
26 821
|
30 434
|
30 276
|
29 933
|
29 183
|
29 105
|
29 354
|
|
| Other Assets |
554
|
7 236
|
6 235
|
5 263
|
3 958
|
3 172
|
2 441
|
1 908
|
1 375
|
843
|
|
| Total Assets |
432 416
N/A
|
468 026
+8%
|
476 885
+2%
|
479 867
+1%
|
484 876
+1%
|
490 106
+1%
|
489 692
0%
|
468 798
-4%
|
478 541
+2%
|
489 509
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
40 564
|
33 479
|
30 466
|
34 649
|
31 275
|
49 977
|
47 367
|
29 697
|
26 076
|
24 140
|
|
| Accrued Liabilities |
1 528
|
1 791
|
1 962
|
2 044
|
2 142
|
2 233
|
2 240
|
2 272
|
2 330
|
2 382
|
|
| Short-Term Debt |
20 387
|
50 704
|
27 291
|
24 670
|
25 746
|
2 000
|
1 300
|
10 220
|
7 590
|
26 700
|
|
| Current Portion of Long-Term Debt |
25 888
|
23 361
|
26 454
|
28 632
|
21 304
|
19 930
|
19 760
|
19 803
|
18 430
|
15 573
|
|
| Other Current Liabilities |
45 729
|
38 628
|
46 716
|
32 225
|
33 015
|
39 822
|
42 929
|
31 843
|
52 638
|
47 279
|
|
| Total Current Liabilities |
134 096
|
147 963
|
132 889
|
122 220
|
113 482
|
113 962
|
113 596
|
93 835
|
107 064
|
116 074
|
|
| Long-Term Debt |
111 491
|
118 924
|
128 354
|
118 633
|
115 923
|
106 996
|
88 352
|
69 341
|
50 530
|
35 456
|
|
| Deferred Income Tax |
1 082
|
2 272
|
2 509
|
2 592
|
1 334
|
1 413
|
980
|
870
|
950
|
1 209
|
|
| Minority Interest |
10 890
|
10 203
|
11 396
|
11 894
|
11 649
|
11 918
|
12 915
|
13 744
|
13 068
|
13 678
|
|
| Other Liabilities |
40 038
|
41 016
|
41 170
|
41 571
|
42 591
|
41 471
|
41 353
|
42 319
|
41 893
|
42 537
|
|
| Total Liabilities |
297 597
N/A
|
320 378
+8%
|
316 318
-1%
|
296 910
-6%
|
284 979
-4%
|
275 760
-3%
|
257 196
-7%
|
220 109
-14%
|
213 505
-3%
|
208 954
-2%
|
|
| Equity | |||||||||||
| Common Stock |
19 613
|
19 613
|
19 613
|
19 613
|
19 613
|
19 613
|
19 613
|
19 613
|
19 613
|
19 613
|
|
| Retained Earnings |
108 283
|
123 785
|
136 070
|
139 951
|
157 530
|
171 751
|
189 072
|
206 121
|
221 682
|
235 852
|
|
| Additional Paid In Capital |
22 282
|
22 577
|
22 493
|
22 247
|
22 247
|
22 267
|
22 545
|
22 580
|
22 753
|
22 753
|
|
| Unrealized Security Profit/Loss |
1 785
|
793
|
1 415
|
1 580
|
737
|
753
|
1 171
|
1 028
|
1 041
|
2 380
|
|
| Treasury Stock |
16 763
|
18 483
|
18 484
|
18
|
25
|
27
|
30
|
800
|
720
|
625
|
|
| Other Equity |
381
|
637
|
540
|
416
|
205
|
11
|
125
|
147
|
667
|
582
|
|
| Total Equity |
134 819
N/A
|
147 648
+10%
|
160 567
+9%
|
182 957
+14%
|
199 897
+9%
|
214 346
+7%
|
232 496
+8%
|
248 689
+7%
|
265 036
+7%
|
280 555
+6%
|
|
| Total Liabilities & Equity |
432 416
N/A
|
468 026
+8%
|
476 885
+2%
|
479 867
+1%
|
484 876
+1%
|
490 106
+1%
|
489 692
0%
|
468 798
-4%
|
478 541
+2%
|
489 509
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
72
|
72
|
72
|
72
|
72
|
72
|
72
|
71
|
71
|
72
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
